0
Letters |

Biotechnology Products and University-Based ScienceBiotechnology Products and University-Based Science

JAMA. 2005;293(23):2861-2863. doi:10.1001/jama.293.23.2861-b
Text Size: A A A
Published online

AUTHOR INFORMATION

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

BIOTECHNOLOGY PRODUCTS AND UNIVERSITY-BASED SCIENCE

To the Editor: In their Special Communication on university-based science and biotechnology products,1 Drs Kesselheim and Avorn reviewed problems related to academic patents and possible solutions. However, the de facto contract between society and universities was not discussed, even though private contributions to universities exceeded 24 billion dollars in 2004.2

Universities exist to collect knowledge, objectively evaluate it, and make it available for students, other scholars, and society. To these ends they are granted unique privileges, which include tax-free status, access to tax deductible gifts, and governmental support. Open flow of information and collaboration among colleagues are fundamental features of academic life. This arrangement allows research to proceed without personal financial risk. Traditionally (as with the Salk vaccine), the public did not pay a second time in the form of royalties when the results were commercialized.

The development of proprietary information requires opposite values. Patents require confidentiality for their certification. Exchanges between professors must now be accompanied by restrictive material transfer agreements. Potential ethical conflicts may arise regarding scientific judgment, patient safety, or universities collecting royalties for essential drugs needed in poor countries.

Universities cannot fulfill their educational and advisory functions while withholding information to earn profit from the marketplace. Either traditional relationships with society will be restored, with the fruits of university research in the public domain, or universities will become purely entrepreneurial entities–competing in the business world without their special advantages.

References
Kesselheim AS, Avorn J. University-based science and biotechnology products: defining the boundaries of intellectual property.  JAMA. 2005;293850-854
PubMed
Arenson KW. Harvard at top of list of donations to colleges. New York Times. March 3, 2005:A22

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Kesselheim AS, Avorn J. University-based science and biotechnology products: defining the boundaries of intellectual property.  JAMA. 2005;293850-854
PubMed
Arenson KW. Harvard at top of list of donations to colleges. New York Times. March 3, 2005:A22
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.